Fluctuating resourcing demand has been a challenge for the broader clinical research industry since the beginning of time. Only recently has the demand for flexible and innovative solutions to address these challenges become more pressing.
Recent studies reveal that out of the more than 5,000 clinical trials that were stopped between December of 2019 and January of 2021, 36% reported suspended, terminated, or withdrawn for reasons that explicitly cite COVID-19.
The launch of the COVID-19 vaccine brings us a glimmer of hope for recovery in the clinical trials space as travel bans are lifted and sites begin to reopen. But how will CROs and sponsors alike recover from the bolus of work collected over the past year?
Tune into our Arena-hosted webinar where Vice President, Catalyst Flex Growth Strategy, Betsy Brown, and Senior Vice President, Resourcing Operations, Kathy Bradrick discuss with guest speaker, Maggie Neptune key outsourced staffing strategies needed by mid-tier biopharma and life sciences companies to achieve study success before, during and in the wake of the pandemic while gaining a sponsor’s perspective on the benefits of a flexible resourcing model.
Key Learning Objectives
- Understand key benefits of an outsourced resourcing model
- Recognize the need for an innovative and flexible response to the bolus of work and ongoing challenges amidst the current landscape and beyond
- Learn best practices for adapting to the specific resourcing needs of complex global studies
Target Audience
- Director of Clinical Operations,
- Clinical Monitoring Director,
- Director Human Resourcing,
- Director,
- Procurement,
- Head of Project Management,
- Director of Project Management,
- Project Manager,
- Senior Project Manager,
- Chief Medical Officer,
- Senior Sourcing Manager,
- Sr Clinical Trial Manager,
- Clinical Trials Manager
